Market Overview

A Peek Into The Market Before The Trading Starts

Related ESRX
Watch These 5 Huge Put Purchases In Tuesday Trade
Benzinga's Option Alert Recap From September 11
Related MIPS
MIP Tech to Get $8.01/Share in Net Proceeds from Recapitilzation
Benzinga's M&A Chatter for Monday December 17, 2012

Pre-open movers US stock futures are higher this morning, ahead of the presidential election. Futures for the Dow Jones Industrial Average surged 41 points to 13,094.00 and S&P 500 index futures rose 4.80 points to 1,416.80. Nasdaq 100 futures gained 13.25 points to 2,675.50.

A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index surged 0.55%, London's FTSE 100 Index rose 0.65%, French CAC 40 Index climbed 0.75% and German DAX 30 index gained 0.69%.

Asian markets ended mixed, with Japan's Nikkei Stock Average falling 0.36%, China's Shanghai Composite dropping 0.38% and Australia's S&P/ASX 200 rising 0.22%. Hong Kong's Hang Seng index declined 0.28% and India's Sensex gained 0.29%.

Broker Recommendation Analysts at Jefferies downgraded Express Scripts Holding Company (NASDAQ: ESRX) from “buy” to “hold.” The target price for Express Scripts has been lowered from $70 to $56.

Express Scripts shares dropped 14.12% to $54.00 in pre-market trading.

Breaking news

  • MIPS Technologies (NASDAQ: MIPS) today announced it has entered into separate definitive agreements with Bridge Crossing LLC, an acquisition vehicle of Allied Security Trust, and Imagination Technologies Group plc with net proceeds of approximately $7.31 per share in cash to each holder of MIPS common stock. To read the full news, click here.
  • CNinsure (NASDAQ: CISG) today announced that its board of directors approved a share repurchase program authorizing the Company to repurchase up to $30 million of its American depositary shares by May 6, 2013. To read the full news, click here.
  • LDK Solar (NYSE: LDK) today announced that it has reached an agreement with Japan-based Sumitomo Corporation to terminate their long-term solar wafer supply agreement. To read the full news, click here.
  • CombiMatrix (NASDAQ: CBMX) today announced that it has entered into a strategic partnership with Pathology. whereby Pathology. will market and distribute CombiMatrix chromosomal microarray tests for the Products of Conception (POC) testing market in designated geographic areas. To read the full news, click here.

Posted-In: Jefferies US Stock FuturesNews Futures Global Pre-Market Outlook Markets


Related Articles (CBMX + CISG)

View Comments and Join the Discussion!